Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InVitro International is a public U.S. company that develops and commercializes proprietary non-animal in vitro safety-testing technologies and related laboratory services. Its core commercial products include the Irritection assay system for ocular and dermal irritation testing and Corrositex for skin corrosivity classification, both aimed at replacing or reducing animal testing. The company serves customers in cosmetics, personal care, chemicals, household products, transportation, and related regulated industries that need safety data for product development and regulatory compliance. In addition to selling assay kits, InVitro International performs outsourced lab testing and customized technology services through its Placentia, California facility and partner laboratory network. The business is best characterized as a commercial-stage specialty testing and assay company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InVitro International.